Skip to main content
SpringerLink
Log in

Hematotoxicity and blood glutathione levels after cisplatin treatment of tumor-bearing mice

  • Published:
Cell Biology and Toxicology Aims and scope Submit manuscript

Abstract

The involvement of glutathione, a major cellular antioxidant, in cisplatin-mediated development of various hematological changes in mice bearing ascites Dalton lymphoma tumor was investigated. With tumor growth, glutathione levels decreased in blood but increased in tumor cells. Cisplatin treatment of tumor-bearing mice caused a decrease in glutathione levels in blood, ascites supernatant, and tumor cells. Blood hemoglobin, erythrocytes, packed cell volume and leukocytes (eosinophils, basophils, and lymphocytes) were also decreased along with the development of various morphological abnormalities in erythrocytes (microcytes, macrocytes, echinocytes, acanthocytes, etc.) after cisplatin treatment. All these hematotoxic features were noted to be increased more when buthionine sulfoximine (a specific glutathione-depleting agent) was also given prior to cisplatin treatment. However, combination treatment of cysteine (precursor for glutathione synthesis) plus cisplatin resulted in an improvement in the glutathione levels and decrease in hematological toxicities. It is noted that the glutathione levels in blood and abnormalities in erythrocytes and other hematological parameters are inversely related in cisplatin-mediated cancer chemotherapy. It is suggested that blood glutathione may play an important role in the development of cisplatin-mediated hematological toxicity in the host.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aydiner A, Aytekin Y, Topuz E. Effect of cisplatin on testicular tissue and the Leydig cell-pituitary axis. Oncology. 1997;54:74–8.

    Article  PubMed  CAS  Google Scholar 

  • Beutler E. Nutritional and metabolic aspects of glutathione. Annu Rev Nutr. 1989;9:287–302.

    Article  PubMed  CAS  Google Scholar 

  • Beutler E, Dunn O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med. 1963;65:882–8.

    Google Scholar 

  • Collins JL, Kao MS. The anticancer drug cisplatin increases the naturally occurring cell-mediated lysis of tumor cells. Cancer Immunol Immunother. 1989;29:17–22.

    Article  PubMed  CAS  Google Scholar 

  • Dacic JV, Lewis SM. Basic haematological techniques. In: Practical haematology. 5th ed. Edinburgh: Churchill Livingstone; 1975:21–67.

    Google Scholar 

  • Della Rovere F, Granata A, Saija A, et al. SH groups and glutathione in cancer patients' blood. Anticancer Res. 2000;20:1595–8.

    PubMed  CAS  Google Scholar 

  • Doll DC, Weiss RB. Chemotherapeutic agents and erythron. Cancer Treat Rev. 1983;10:185–200.

    Article  PubMed  CAS  Google Scholar 

  • Durak I, Akyol O, Baseme E, Canbolat O, Kavuteu M. Reduced crythrocyte defence mechanisms against free radical toxicity in patients with chronic renal failure. Nephron. 1994;66:76–80.

    Article  PubMed  CAS  Google Scholar 

  • Estrela JM, Hernandez R, Terradez P, Asensi M, Puertes LR, Vina J. Regulation of glutathione metabolism in Ehrlich ascites tumour cells. Biochem J. 1992;286:257–62.

    PubMed  CAS  Google Scholar 

  • Estrela JM, Obrador E, Navarro J, Lasso de la Vega MC, Pellicer JA. Elimination of Ehrlich tumours by ATP-induced growth inhibition, glutathione depletion and X-rays. Nature Med. 1995;1:84–8.

    Article  PubMed  CAS  Google Scholar 

  • Giri A, Khynriam D, Prasad SB. Vitamin C mediated protection on cisplatin-induced mutagenicity in mice. Mutat Res. 1998;421:139–48.

    PubMed  CAS  Google Scholar 

  • Go RS, Adjei AA. Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. J Clin Oncol. 1999;17:409–22.

    PubMed  CAS  Google Scholar 

  • Griffith OW, Meister A. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine. J Biol Chem. 1987;254:7558–60.

    Google Scholar 

  • Hamers FPT, Gispen WH, Neigt JP. Neurotoxic side effects of cisplatin. Eur J Cancer. 1991;27:372–6.

    Article  CAS  Google Scholar 

  • Hamilton TC, Winker MA, Louie KG, et al. Augmentation of adriamycin, melphalan and cisplatin cytotoxicity in drug resistant and sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion. Biochem Pharmacol. 1985;34:2583–6.

    Article  PubMed  CAS  Google Scholar 

  • Hoagland HC. Hematological complications of cancer chemotherapy. Semin Oncol. 1982;9:95–102.

    PubMed  CAS  Google Scholar 

  • Ishikawa T, Ali-Osman, F. Glutathione-associated cis-diamminedichloroplatinum (II) metabolism and ATP-dependent efflux from leukemia cells. J Biol Chem. 1993;268:20116–25.

    PubMed  CAS  Google Scholar 

  • Jurga L, Misurova E, Kovac V, Sevcikova I. The role of cisplatin in chemotherapy of advanced breast cancer. Neoplasma 1994;41:347–52.

    PubMed  CAS  Google Scholar 

  • Keller KA, Aggarwal SK. Embryotoxicity of cisplatin in rats and mice. Toxicol Appl Pharmacol. 1983;69:245–66.

    Article  PubMed  CAS  Google Scholar 

  • Kharbangar A, Khynriam D, Prasad SB. Effect of cisplatin on mitochondrial protein, glutathione and succinate dehydrogenase in Dalton lymphoma-bearing mice. Cell Biol Toxicol. 2000;16:363–73.

    Article  PubMed  CAS  Google Scholar 

  • Krakoff IH, Nephrotoxicity of cis-dichlorodiammineplatinum. Cancer Treat Rep. 1979;63:1523–5.

    PubMed  CAS  Google Scholar 

  • Meister A. Glutathione metabolism and its selective modification. J Biol Chem. 1988;263:17205–8.

    PubMed  CAS  Google Scholar 

  • Meister A. Glutathione-ascorbic acid antioxidant system in animals. J Biol Chem. 1994;269:9397–400.

    PubMed  CAS  Google Scholar 

  • Michelet F, Gueguen R, Leroy P, Wellman M, Nicolas A, Siest G. Blood and plasma glutathione measured in healthy subjects by HPLC: relation to sex, aging, biological variables and life habits. Clin Chem. 1995;41:1509–17.

    PubMed  CAS  Google Scholar 

  • Mistry P, Loh SY, Kelland LR, Harrap KR. Effect of buthionine sulfoximine on Pt II and Pt IV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines. Int J Cancer. 1993;55:848–56.

    PubMed  CAS  Google Scholar 

  • Murakami K, Kondo T, Ohtsuka Y, Fujiwara Y, Shimada M, Kawakami Y. Impairment of glutathione metabolism in erythrocytes from patients with diabetes mellitus. Metabolism. 1989;38:753–8.

    Article  PubMed  CAS  Google Scholar 

  • Navarro J, Obrador E, Carretero J, et al. Changes in glutathione status and the antioxidant system in blood and in cancer cells associate with tumour growth in vivo. Free Radic Biol Med. 1999;26:410–18.

    Article  PubMed  CAS  Google Scholar 

  • Ohno S, Strebel FR, Stephens LC, et al. Haematological toxicity of carboplatin and cisplatin combined with whole body hyperthermia in rats. Br J Cancer. 1993;68:469–74.

    PubMed  CAS  Google Scholar 

  • Olas B, Wachowicz B. Modulation of cisplatin toxicity in blood platelets by glutathione depletion. Anticancer Drugs. 1998;9:473–8.

    PubMed  CAS  Google Scholar 

  • Pal S, Ray MR, Maity P. Tumor inhibition and haematopoitic stimulation in mice by a synthetic copper-ATP complex. Anticancer Drugs. 1993;4:505–10.

    PubMed  CAS  Google Scholar 

  • Pascoe JM, Roberts JJ. Interactions between mammalian cell DNA and inorganic platinum compounds. Biochem Pharmacol. 1974;23:1345–57.

    Article  PubMed  CAS  Google Scholar 

  • Pikula S, Pikula JB, Awasthi S, Awasthi YC. ATP-driven efflux of glutathione-conjugates, antitumor drugs and xenobiotics from human erythrocytes. Biochem Arch. 1996;12:261–71.

    CAS  Google Scholar 

  • Pinto AL, Lippard SJ. Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNA. Biochim Biophys Acta. 1985;780:167–80.

    PubMed  CAS  Google Scholar 

  • Prasad SB, Giri A. Antitumour effect of cisplatin against murine ascites Dalton's lymphoma. Ind J Exp Biol. 1994;32:155–62.

    CAS  Google Scholar 

  • Prasad SB, Khokhar AR, Siddik ZH. Potentiation by L-buthionine sulfoximine (BSO) of cytotoxicity of platinum(IV) complexes in sensitive and resistant human ovarian carcinoma cells. In: Collery P, Poirier LA, Littlefield NA, Etienne JC, eds. Metal ions in biology and medicine. Paris: John Libbey Eurotext; 1994:36–70.

    Google Scholar 

  • Prasad SB, Giri A, Khynriam D. Studies on the chromosomes of murine Dalton's lymphoma cells and the effect of cisplatin on chromosomes of these cells and bone marrow cells in vivo. Cytologia. 1998;63:405–13.

    CAS  Google Scholar 

  • Prasad SB, Sodhi A. Effect of cis-dichlorodiammineplatinum(II) on the agglutinability of tumor and normal cells with concanavalin A and wheat germ agglutinin. Chem Biol Interact. 1981;36:355–67.

    Article  PubMed  CAS  Google Scholar 

  • Prasad SB, Giri A. Cisplatin-induced changes in tissue calcium and potassium concentrations in tumour-bearing mice. Med Sci Res. 1999;27:459–62.

    CAS  Google Scholar 

  • Prasad SB, Giri A, Khynriam D, Kharbangar A, Nicol BM, Lotha C. Cisplatin-mediated enzymatic changes in mice bearing ascites Dalton's lymphoma. Med Sci Res. 1999;27:723–30.

    CAS  Google Scholar 

  • Price VE, Greenfield RE. Anemia in cancer. In: Greenstein JP, Haddow A, eds. Advances in cancer research. Vol. 5. New York: Academic Press; 1958:199–290.

    Google Scholar 

  • Rosenberg B. Fundamental studies with cisplatin. Cancer. 1985;55:2303–16.

    Article  PubMed  CAS  Google Scholar 

  • Ross EA, Koo LC, Moberly JB. Low whole blood and erythrocyte levels of glutathione in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 1997;30:489–94.

    PubMed  CAS  Google Scholar 

  • Roum JH, Buhl R, McElvaney NG, Borok Z, Crystal RG. Systemic deficiency of glutathione in cystic fibrosis. J Appl Physiol. 1993;75:2419–24.

    PubMed  CAS  Google Scholar 

  • Sedlak J, Lindsay RH. Estimation of total, protein-bound and non-protein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem. 1968;25:192–205.

    Article  PubMed  CAS  Google Scholar 

  • Shaw JP, Chou IN. Elevation of intracellular glutathione content associated with mitogenic stimulation of quiscent fibroblasts. J Cell Physiol. 1986;129:193–8.

    Article  PubMed  CAS  Google Scholar 

  • Shi MM, Kugelman A, Iwamoto T, Tian L, Forman HJ. Quinone induced oxidative stress elevates glutathione and induces gamma-glutamyl cystcine synthetase activity in rat lung epithelial L2 cells. J Biol Chem. 1994;269:26512–7.

    PubMed  CAS  Google Scholar 

  • Staal J, Ela S, Roederer M, Anderson M, Herzenberg M, Herzenberg L. Glutathione deficiency and human immunodeficiency virus infection. Lancet. 1992;339:909–12.

    Article  PubMed  CAS  Google Scholar 

  • Swarup H, Pathak SC, Arora S. In: Laboratory techniques in modern biology. New Delhi: Kalyani publishers; 1981:163–86.

    Google Scholar 

  • Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 1991;51:794–8.

    PubMed  CAS  Google Scholar 

  • Terradez P, Asensi M, Lasso de la Vega MC, Puertes I, Vina J, Estrela JM. Depletion of tumor glutathione in vivo by buthionine sulfoximine: modulation by the rate of cellular proliferation and inhibition of cancer growth. Biochem J. 1993;292:477–83.

    PubMed  CAS  Google Scholar 

  • Van Klaveren RT, Demedts M, Nemery B. Cellular glutathione turnover in vitro with emphasis on type II pneumocytes. Eur Respir J. 1997;10:1392–1400.

    Article  PubMed  CAS  Google Scholar 

  • Wang W, Ballatori N. Endogenous glutathione conjugates: occurrence and biological functions. Pharmacol Rev. 1998;50:335–55.

    PubMed  CAS  Google Scholar 

  • Zamble BD, Lippard SJ. Cisplatin and DNA repair in cancer chemotherapy. Trends Biochem Sci. 1995;20:435–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cell and Tumor Biology Laboratory, Department of Zoology, North-Eastern Hill University, Shillong, India

    D. Khynriam & S.B. Prasad

Authors
  1. D. Khynriam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S.B. Prasad
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khynriam, D., Prasad, S. Hematotoxicity and blood glutathione levels after cisplatin treatment of tumor-bearing mice. Cell Biol Toxicol 17, 357–370 (2001). https://doi.org/10.1023/A:1013784115683

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1013784115683

Search

Navigation